Securities Code: 300685 Securities Abbreviation: Ad Biomedicine Announcement No.: 2026-035 Xiamen Ad Biomedicine Inc. Announcement on the Planning of the Change of Company Control and Continued Suspension of Trading The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Overview of Trading Suspension
Xiamen Ad Biomedicine Inc. (hereinafter referred to as the "Company")'s controlling shareholder, Qianzhan Investment (Hong Kong) Co., Ltd., is planning a change of company control. This matter may lead to a change in the Company's controlling shareholder and actual controller. To protect investor interests and avoid a significant impact on the Company's stock price, upon application to the Shenzhen Stock Exchange, the Company's shares (Securities Abbreviation: Ad Biomedici